FDA Inspection 824387 — Livzon New North River Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon New North River Pharmaceutical Co., Ltd. on March 22, 2013 in Qingyuan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qingyuan (China)